Redox regulation of human estrogen sulfotransferase (hSULT1E1)

Biochemical Pharmacology

Volumn 73, Issue 9, 2007, Pages 1474-1481

  Maiti, Smarajit ^a,b   Zhang, Jimei ^a,c   Chen, Guangping ^a  

^a OKLAHOMA STATE UNIVERSITY   (United States)

^b Oriental Institute of Science and Technology   (India)

^c TIANJIN POLYTECHNIC UNIVERSITY   (China)

Author keywords

Estrogen; Estrogen sulfotransferase; Redox regulation; Sulfotransferase; SULT1E1

Indexed keywords

ACETYLCYSTEINE; ADENOSINE 3' PHOSPHATE 5' PHOSPHOSULFATE; BUTHIONINE SULFOXIMINE; CYSTEINE; ESTROGEN SULFOTRANSFERASE; GLUTATHIONE DISULFIDE;

AMINO ACID COMPOSITION; ARTICLE; CATALYSIS; CELL STRAIN HEPG2; ENZYME ACTIVITY; ENZYME REGULATION; ESTROGEN METABOLISM; GLUTATHIONE METABOLISM; HUMAN; HUMAN CELL; OXIDATION REDUCTION STATE; PRIORITY JOURNAL; SITE DIRECTED MUTAGENESIS; STRUCTURE ACTIVITY RELATION; SULFATION;

AMINO ACID SUBSTITUTION; HUMANS; MUTAGENESIS, SITE-DIRECTED; OXIDATION-REDUCTION; SULFOTRANSFERASES;

EID: 33947402331     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2006.12.026     Document Type: Article

References (37)

1. Coughtrie M.W. Sulfation through the looking glass-recent advances in sulfotransferase research for the curious. Pharmacogenomics J 2 (2002) 297-308
2. Duffel M.W., Marshal A.D., McPhie P., Sharma V., and Jakoby W.B. Enzymatic aspects of the phenol (aryl) sulfotransferases. Drug Metab Rev 33 (2001) 369-395
3. Falany C.N. Enzymology of human cytosolic sulfotransferases. FASEB J 11 (1997) 206-216
4. Dooley T.P. Cloning of the human phenol sulfotransferase gene family: three genes implicated in the metabolism of catecholamines, thyroid hormones and drugs. Chem Biol Interact 109 (1998) 29-41
5. Roy A.K., Lavrovsky Y., Song C.S., Chen S., Jung M.H., Velu N.K., et al. Regulation of androgen action. Vitamins & Hormones 55 (1999) 309-352
6. Glatt H. Sulfotransferases in the bioactivation of xenobiotics. Chem Biol Interact 129 (2000) 141-170
7. Duanmu Z., Weckle A., Koukouritaki S.B., Hines R.N., Falany J.L., Falany C.N., et al. Developmental expression of aryl, estrogen, and hydroxysteroid sulfotransferases in pre- and postnatal human liver. J Pharmacol Exp Ther 316 (2006) 1310-1317
8. Iwamori M. Estrogen sulfatase. Methods Enzymol 400 (2005) 293-302
9. Rahman I. Regulation of glutathione in inflammation and chronic lung diseases. Mutat Res 579 (2005) 58-80
10. Ghezzi P. Regulation of protein function by glutathionylation. Free Radic Res 39 (2005) 573-580
11. Chen F.C., and Ogut O. Decline of contractility during ischemia-reperfusion injury: actin glutathionylation and its effect on allosteric interaction with tropomyosin. Am J Physiol Cell Physiol 290 (2006) C719-C727
12. Aracena P., Tang W., Hamilton S.L., and Hidalgo C. Effects of S-glutathionylation and S-nitrosylation on calmodulin binding to triads and FKBP12 binding to type 1 calcium release channels. Antioxid Redox Signal 7 (2005) 870-881
13. Niedowicz D.M., and Daleke D.L. The role of oxidative stress in diabetic complications. Cell Biochem Biophys 43 (2005) 289-330
14. Wu G., Fang Y.Z., Yang S., Lupton J.R., and Turner N.D. Glutathione metabolism and its implications for health. J Nutr 134 (2004) 489-492
15. Cross J.V., and Templeton D.J. Oxidative stress inhibits MEKK1 by site-specific glutathionylation in the ATP-binding domain. Biochem J 381 (2004) 675-683
16. Di Stefano A., Frosali S., Leonini A., Ettorre A., Priora R., Di Simplicio F.C., et al. GSH depletion, protein S-glutathionylation and mitochondrial transmembrane potential hyperpolarization are early events in initiation of cell death induced by a mixture of isothiazolinones in HL60 cells. Biochim Biophys Acta 1763 (2006) 214-225
17. Dixon D.P., Fordham-Skelton A.P., and Edwards R. Redox regulation of a soybean tyrosine-specific protein phosphatase. Biochemistry 44 (2005) 7696-7703
18. Marshall A.D., McPhie P., and Jakoby W.B. Redox control of aryl sulfotransferase specificity. Arch Biochem Biophys 382 (2000) 95-104
19. Maiti S., Dutta S.M., Baker S.M., Zhang J., Narasaraju T., Liu L., et al. In vivo and in vitro oxidative regulation of rat aryl sulfotransferase IV (AST IV). J Biochem Mol Toxicol 19 (2005) 109-118
20. Maiti S., Grant S., Baker S.M., Karanth S., Pope C.N., and Chen G. Stress regulation of sulfotransferases in male rat liver. Biochem Biophys Res Commun 323 (2004) 235-241
21. Maiti S., Chen X., and Chen G. All-trans retinoic acid induction of sulfotransferases. Basic Clin Pharmacol Toxicol 96 (2005) 44-53
22. Chen X., Baker S.M., and Chen G. Methotrexate induction of human sulfotransferases in Hep G2 and Caco-2 cells. J Appl Toxicol 25 (2005) 354-360
23. Maiti S., and Chen G. Methotrexate is a novel inducer of rat liver and intestinal sulfotransferases. Arch Biochem Biophys 418 (2003) 161-168
24. Maiti S., and Chen G. Tamoxifen induction of aryl sulfotransferase and hydroxysteroid sulfotransferase in male and female rat liver and intestine. Drug Metab Dispos 31 (2003) 637-644
25. Shen D.X., Shi X., Fu J.L., Zhang Y.M., and Zhou Z.C. The role of thiol reduction in hydroquinone-induced apoptosis in HEK293 cells. Chem Biol Interact 145 (2003) 225-233
26. Falany C.N., Krasnykh V., and Falany J.L. Bacterial expression and characterization of a cDNA for human liver estrogen sulfotransferase. J Steroid Biochem Mol Biol 52 (1995) 529-539
27. Chen G., and Chen X. Arginine residues in the active site of human phenol sulfotransferase (SULT1A1). J Biol Chem 278 (2003) 36358-36364
28. Hirano S., Kobayashi Y., Cui X., Kanno S., Hayakawa T., and Shraim A. The accumulation and toxicity of methylated arsenicals in endothelial cells: important roles of thiol compounds. Toxicol Appl Pharmacol 198 (2004) 458-467
29. Falany C.N., Zhuang W., and Falany J.L. Characterization of expressed human phenol-sulfating phenol sulfotransferase: effect of mutating cys70 on activity and thermostability. Chem Biol Interact 92 (1994) 57-66
30. Nakayama T., Tanabe H., Deyashiki Y., Shinoda M., Hara A., and Sawada H. Chemical modification of cysteinyl, lysyl and histidyl residues of mouse liver 17 beta-hydroxysteroid dehydrogenase. Biochim Biophys Acta 1120 (1992) 144-150
31. Inano H. Chemical modification of lysine residues at active-site of human placental estradiol 17 beta-dehydrogenase. Biochem Biophys Res Commun 152 (1988) 789-793
32. Garban H.J., Marquez-Garban D.C., Pietras R.J., and Ignarro L.J. Rapid nitric oxide-mediated S-nitrosylation of estrogen receptor: regulation of estrogen-dependent gene transcription. Proc Natl Acad Sci USA 102 (2005) 2632-2636
33. Brzozowski A.M., Pike A.C., Dauter Z., Hubbard R.E., Bonn T., Engstrom O., et al. Molecular basis of agonism and antagonism in the oestrogen receptor. Nature 389 (1997) 753-758
34. Nahoum V., Gangloff A., Shi R., and Lin S.X. How estrogen-specific proteins discriminate estrogens from androgens: a common steroid binding site architecture. FASEB J 17 (2003) 1334-1336
35. Wang M., Tsai B.M., Reiger K.M., Brown J.W., and Meldrum D.R. 17-beta-Estradiol decreases p38 MAPK-mediated myocardial inflammation and dysfunction following acute ischemia. J Mol Cell Cardiol 40 (2006) 205-212
36. Nakamura Y., Suzuki T., Fukuda T., Ito A., Endo M., Moriya T., et al. Steroid sulfatase and estrogen sulfotransferase in human prostate cancer. Prostate 66 (2006) 1005-1012
37. Suzuki T., Miki Y., Nakamura Y., Moriya T., Ito K., Ohuchi N., et al. Sex steroid-producing enzymes in human breast cancer. Endocr Relat Cancer 12 (2005) 701-720